Cargando…

191. Appropriateness of Empiric Antibiotics for Enterobacteriaceae Bacteremia

BACKGROUND: Appropriate empiric antibiotic therapy is associated with decreased mortality and recurrence in patients with Enterobacteriaceae bacteremia (EB). Increasing bacterial resistance adds an additional layer to this complex clinical scenario. Swift utilization of appropriate antibiotics is cr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Brandon J, Kois, Abigail, Gartland, Nathan, Tholany, Joseph, Arbulu, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809945/ http://dx.doi.org/10.1093/ofid/ofz360.266

Ejemplares similares

Factors Associated with Mortality in Carbapenem-Resistant Enterobacteriaceae Bacteremia: Focus on Antibiotic Therapy
por: Pillinger, Kelly E, et al.
Publicado: (2017)

Comparing the Outcomes of Adults with Enterobacteriaceae Bacteremia Receiving Short-Course vs Prolonged-Course Antibiotic Therapy
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2017)

1179. Incidence of Bacteremia and Bacteriuria With Antibiotic-Resistant Enterobacteriaceae After Transrectal Ultrasound-Guided Biopsy of the Prostate (TRUSBP)
por: Saade, Elie, et al.
Publicado: (2018)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

158. The Effect of Insurance Coverage on Appropriate Selection of Hospital Discharge Antibiotics for Staphylococcus aureus Bacteremia
por: McHale, Thomas, et al.
Publicado: (2018)

182. Appropriateness of Treatment Duration for S. aureus Bacteremia (SAB)
por: Griebe, Kristin, et al.
Publicado: (2019)

191. Accuracy of Clinical Indications for Use When Ordering Antibiotics for Cystitis in Community Hospitals
por: Khadem, Tina, et al.
Publicado: (2018)

1826. Impact of Rapid Diagnostics and Ceftazidime–Avibactam on Mortality after Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae
por: Satlin, Michael J, et al.
Publicado: (2019)

1796. Inappropriate Aztreonam Usage Identified as an Opportunity to Reduce Pharmaceutical Expenditures
por: Smith, Brandon, et al.
Publicado: (2018)

848. Low-Bioavailability vs. High-Bioavailability Oral Antibiotics for the Definitive Treatment of Enterobacteriaceae Bacteremia from Suspected Urine Source in Hospitalized Veterans
por: Sutton, Jesse D, et al.
Publicado: (2019)

1072. Streamlining to Oral β-Lactam vs. Fluoroquinolone as Definitive Therapy for Enterobacteriaceae Bacteremia
por: Fong, Karen, et al.
Publicado: (2018)

959 Epidemiology and Treatment of Enterobacteriaceae Bacteremia: Combination vs Monotherapy
por: Berkowitz, Nina, et al.
Publicado: (2014)

Impact of an Emergency Medicine Pharmacist on Appropriate Empiric Antibiotic Prescribing for Community-Acquired Pneumonia and Intra-Abdominal Infections
por: Kulwicki, Benjamin, et al.
Publicado: (2017)

518. Comparing the Mortality of Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia
por: Seo, Hyeonji, et al.
Publicado: (2019)

Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia
por: Lee, Ching-Chi, et al.
Publicado: (2017)

Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae?
por: Alhashem, Fatema, et al.
Publicado: (2017)

262. A Systematic Review and Meta-Analysis of the Impact of Delayed Appropriate Antibiotic Therapy on Mortality in Patients with Gram-Positive Bacteremia
por: Liu, Steve, et al.
Publicado: (2020)

1055. Epidemiology and Mechanisms of Carbapenem Resistance in Recurrent Extended-Spectrum β-Lactamase- Producing Enterobacteriaceae Bacteremia
por: Aitken, Samuel L, et al.
Publicado: (2018)

1885. Cost-Effectiveness of Ceftazidime–Avibactam Compared With Colistin for Treatment of Carbapenem-Resistant Enterobacteriaceae Bacteremia and Pneumonia
por: Sfeir, Maroun, et al.
Publicado: (2018)

211. Disease burden of bacteremia with extended-spectrum beta-lactamase-producing or carbapenem-resistant Enterobacteriaceae in Korea
por: Mi Lee, Chan, et al.
Publicado: (2023)

1025. Inappropriate Aztreonam Usage – Antimicrobial Stewardship Strikes Back
por: Smith, Brandon J, et al.
Publicado: (2019)

Clinical Impact of Revised Cefepime Breakpoint in Patients With Enterobacteriaceae Bacteremia
por: Foong, Kap Sum, et al.
Publicado: (2019)

2442. Outcomes in ESBL Bacteremia Empirically Treated With Piperacillin/Tazobactam or Carbapenems
por: John, Reeba, et al.
Publicado: (2018)

2558. Pharmacy Students’ Perceptions and Confidence to Recommend Appropriate Empiric Antibiotic Therapy in Infective Endocarditis Following Mannequin-Based Simulation
por: Kufel, Wesley D, et al.
Publicado: (2019)

191. Oral Antibiotic Step-Down Therapy for Non-Staphylococcal Gram-Positive Bloodstream Infections
por: Gandhi, Kelvin, et al.
Publicado: (2021)

Carbapenem-resistant Enterobacteriaceae (CRE) or Delayed Appropriate Therapy (DAT)—Does One Affect Outcomes More Than the Other Among Patients With Serious Infections Due to Enterobacteriaceae?
por: Lodise, Thomas, et al.
Publicado: (2017)

ASP Strategies and Appropriate Antibiotic Use
por: Lee, Brian R, et al.
Publicado: (2017)

Predictors of Appropriate Antibiotic Use in Bacteremia Patients Presenting at the Emergency Department
por: Phungoen, Pariwat, et al.
Publicado: (2019)

2246. Improved Outcomes for Cancer Patients Treated With Ceftazidime–Avibactam vs. Polymyxin-Containing Regimens for Carbapenem-Resistant Enterobacteriaceae Bacteremia
por: Borjan, Jovan, et al.
Publicado: (2019)

1588. Clinical Prediction Tool for Extended-Spectrum Β Lactamase-Producing Enterobacteriaceae as the Etiology of Bacteremia in Solid Organ Transplant Recipients
por: Wang, Rebecca, et al.
Publicado: (2018)

2432. Appropriateness of Empiric Extended-Infusion Piperacillin/Tazobactam in the Intensive Care Unit
por: Tucker, Kendall, et al.
Publicado: (2018)

The Effect of Insurance on Appropriate Hospital Discharge Antibiotics for Patients With Staphylococcus aureus Bacteremia
por: McHale, Thomas, et al.
Publicado: (2020)

Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials
por: Burnham, Jason P., et al.
Publicado: (2017)

Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitis
por: Park, Ki-Ho, et al.
Publicado: (2019)

Sepsis: impact of timely and appropriate empirical antibiotic therapy on mortality
por: Serpa-Pinto, L, et al.
Publicado: (2014)

972. Imipenem-Cilastatin-Relebactam (I/R) Pharmacokinetics (PK) in Critically Ill Patients Supported on Extracorporeal Membrane Oxygenation (ECMO)
por: Fratoni, Andrew J, et al.
Publicado: (2023)

1599. Clinical Outcomes for Patients Treated with Fluoroquinolones for Bacteremia Caused by Enterobacteriaceae Reclassified as Not Susceptible by Updated CLSI Breakpoints
por: Fleischner, Zachary, et al.
Publicado: (2020)

1842. Intravenous to Oral Antibiotic Stepdown for Uncomplicated Streptococcal Bacteremia
por: Salam, Madison E, et al.
Publicado: (2022)

Diabetes does not affect outcome in patients with Enterobacteriaceae bacteremia
por: Peralta, Galo, et al.
Publicado: (2009)

Beneficial effects of early empirical administration of appropriate antimicrobials on survival and defervescence in adults with community-onset bacteremia
por: Lee, Ching-Chi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cd0rg85jc45nvfrc1n85h2t6mt